This bill requires Utah healthcare facilities to provide parents or legal guardians full access to minors' electronic medical records, unless exceptions apply (such as a minor's consent for specific treatments, a court order, or if the parent isn't legally authorized under state/federal law). It mandates electronic health record vendors to ensure systems support this access and authorizes the attorney general to enforce compliance with fines up to $10,000 per day. Facilities must also provide paper records free of charge upon request if electronic access is restricted. The law takes effect May 6, 2026, and aligns with federal privacy standards.
SB 45 repeals Utah's 2019 Kratom Consumer Protection Act and classifies alkaloids found in kratom as Schedule I controlled substances under state law. This change directly affects kratom users and businesses in Utah, removing previous regulatory protections and making kratom possession or sale illegal under state law. The bill amends Utah's controlled substances code to include kratom alkaloids in Schedule I, which prohibits use due to no accepted medical purpose and high abuse potential. This policy shift reverses prior regulations that allowed regulated sale and use of kratom products.
HB 527 amends Utah's pharmacy pricing rules to require pharmacy benefit managers to base reimbursement rates only on drugs rated "A" or "B" in the FDA's Orange Book (or similar ratings) that are not obsolete and generally available in the state. It clarifies key terms like "maximum allowable cost" and "rebate," and grants the Insurance Department authority to create implementing rules. This directly affects pharmacies, pharmacy benefit managers, and insurers by changing how drug reimbursement rates are calculated. The bill does not appropriate funds or create new taxes.
HB 258 requires health insurance plans in Utah to cover reversal treatments for gender transition if the plan covers transition-related care. Specifically, plans covering hormonal transgender treatments must also cover reversal hormonal treatments, and plans covering surgical sex transition procedures must cover reversal surgeries. This applies to all health benefit plans renewed or entered into on or after January 1, 2027. The bill directly affects insurers and policyholders by mandating this coverage, without appropriating funds or adding new administrative requirements.
SB 31 amends Utah's professional licensure laws for health care providers, directly affecting physical therapists, occupational therapists, acupuncturists, nurse practitioners, and medication aides. It expands practice authority - allowing physical therapists to prescribe medical equipment and order certain imaging, and letting occupational therapists prescribe adaptive devices - and changes licensing requirements, such as replacing certification with a license for medication aides. The bill also increases registered nursing experience needed for nurse practitioner licensure, adjusts supervision rules for therapists, and clarifies prescriptive powers for acupuncturists. These changes aim to modernize scope-of-practice standards while maintaining safety protocols.
HB 480 amends Utah's medical record laws to clarify abortion classifications. It defines "elective abortion" as one not needed for health reasons and "medically indicated abortion" as one required to save a woman's life, treat a pregnancy loss, or address serious health risks. The bill allows patients to request that their medical records reflect a prior abortion as "not elective" (i.e., medically necessary), and requires healthcare providers to update records upon such a request. These changes affect patients who have had abortions and the healthcare providers maintaining their records, with no new funding or major procedural shifts.
HB 257 requires pharmacies, not the state, to provide patients receiving opiate prescriptions with a pamphlet covering addiction risks, safe storage/disposal methods, pain management alternatives, naloxone benefits, and substance use disorder resources. The pamphlets must be written in simple language, available in multiple languages, and periodically reviewed for effectiveness. The bill takes effect on May 6, 2026, with no new state funding required. It directly affects pharmacies dispensing opiates and patients receiving such prescriptions.